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Abstract
Background
Large genome-wide association (GWA) studies of European ancestry individuals have
identified multiple genetic variants influencing iron status. Studies on the generalizability of
these associations to African ancestry populations have been limited. These studies are
important given interethnic differences in iron status and the disproportionate burden of iron
deficiency among African ancestry populations.
Methods
We tested the associations of 20 previously identified iron status-associated single nucleo-
tide polymorphisms (SNPs) in 628 Kenyans, 609 Tanzanians, 608 South Africans and 228
African Americans. In each study, we examined the associations present between 20 SNPs
with ferritin and haemoglobin, adjusting for age, sex and CRP levels.
Results
In the meta analysis including all 4 African ancestry cohorts, we replicated previously
reported associations with lowered haemoglobin concentrations for rs2413450 (β = -0.19, P
= 0.02) and rs4820268 (β = -0.16, P = 0.04) in TMPRSS6. An association with increased fer-
ritin concentrations was also confirmed for rs1867504 in TF (β = 1.04, P = <0.0001) in the
meta analysis including the African cohorts only.
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Conclusions
In all meta analyses, we only replicated 4 of the 20 single nucleotide polymorphisms
reported to be associated with iron status in large GWA studies of European ancestry indi-
viduals. While there is now evidence for the associations of a number of genetic variants
with iron status in both European and African ancestry populations, the considerable lack of
concordance highlights the importance of continued ancestry-specific studies to elucidate
the genetic underpinnings of iron status in ethnically diverse populations.
Introduction
Body iron status is influenced by a combination of genes as well as environmental factors such
as diet, blood loss, pregnancy, alcohol intake and infections [1, 2]. In order to maintain iron
levels within normal ranges and thus prevent iron excess or iron deficiency, iron homeostasis
has evolved as a complex trait and a tightly coordinated process of interaction between genes
and environmental factors. Whether genetic influences on iron metabolism may influence iron
status at the public health level, is a subject of recent interest. This is of interest since segments
of populations that are genetically prone to iron deficiency can be specifically targeted with
interventions.
Understanding the genetic underpinnings of low iron status is particularly relevant for Afri-
can ancestry populations, who experience a disproportionately high burden of low iron status.
In particular, it has been observed that in the US, African-Americans have lower haemoglobin
concentrations and serum transferrin saturation (TS), and higher serum ferritin (SF) concen-
trations compared to individuals of European Ancestry [3]. Furthermore, according to WHO
regional prevalence estimates, Africa has the highest proportion of individuals affected by
anaemia worldwide [4].
Previous studies on iron status report heritability estimates ranging from of 20% to 30%,
supporting a genetic component to iron status [5, 6]. Genome-wide association (GWA) studies
have identified common variants that are associated with iron status in largely European ances-
try populations [7–10]. It is questionable however whether these findings can be generalized to
African ancestry populations. Given the greater levels of linkage disequilibrium among Euro-
pean-ancestry individuals [11], it is expected that index single nucleotide polymorphisms
(SNPs) tag larger regions of the genome than they would among African ancestry individuals.
Therefore index SNPs in European populations may not necessarily tag causal variants within
the African population. Moreover, African populations are exposed to very different environ-
mental factors that further influence iron status. Recently, genetic studies on iron status have
been conducted in the African American population [12–16]. This population has varying
degrees of admixture that may complicate transferability of these results to African populations
[17]. Conclusive inferences about the potential generalization of previous findings to African
ancestry populations have been precluded by the lack of data from African cohorts. In part this
has been due to the fact that it is challenging to find African cohorts which can be utilized in
genetic epidemiologic studies. In the present study, we utilized data from four African ancestry
cohorts that were initiated with different primary hypotheses but had collected the necessary
phenotypic and genetic data to address the question regarding the genetic architecture of iron
metabolism. We investigated 20 SNPs previously reported to be associated with iron status in
GWA studies [7, 8, 10, 14, 18] with haematological indicators in several African ancestry
populations.
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Methods
Study area and population
Four cohorts of African ancestry were selected; from Kenya (n = 628), Tanzania (n = 609);
South Africa (n = 686) and the United States of America (n = 228). The four cohorts differed
largely in age, gender and burden of inflammation as described in more detail below.
Kenyan cohort. Samples were obtained from both a cross sectional study and from the
baseline data of a randomized trial (Cassavita study) designed to assess the efficacy of bio-forti-
fied cassava to improve vitamin A deficiency [19, 20]. The cross sectional study was conducted
in June 2010. The randomized trial (Cassavita study) was conducted fromMay until November
2012 in 3 primary schools in Kibwezi District, Kenya. Haematological markers were measured
prior to the start of the trial. As determined by self-report in both studies children were of
Akamba (Bantu) ancestry. Blood samples for the cross-sectional study were collected from
children aged 6–12 years (n = 375) who were located in the Kibwezi and Makindu Districts in
Eastern Kenya, which is a low malarial transmission area [21]. Blood samples for the random-
ized trial were collected from children aged 5–13 years (n = 342) in three primary schools
located in the Kibwezi District. Children with lowest retinol-binding protein concentrations
were included in the trial to select for those with the lowest vitamin A status. All subjects (for
both the trial and cross sectional study) were apparently healthy and without fever (ear drum
temperature< 37.5°C) upon examination by the research physician and children with inflam-
mation (C-reactive protein concentration> 8mg/L), low haemoglobin concentrations (<70 g/
L), or Plasmodium infection were excluded.
The cross sectional study as well as the trials were approved by ethical committees in Kenya
and the Netherlands (ClinicalTrials.gov:NCT01614483). Written informed consent was
obtained from parents or guardians, and assent from children.
Tanzanian cohort. Children in this cohort were part of a randomized placebo controlled
trial (MACH study) [22]. Data were collected between February 2008 and March 2009. Haema-
tological markers as were measured in samples collected prior to the start of the trial and ances-
try was self-reported. People in this area originally belonged to the Wazigua and Wabondei
Bantu tribes, but settlement of migrant plantation workers in the past has resulted in the
admixture of many tribes with different origins. Samples were obtained from children aged
6–60 months (n = 612) with height-for-age z-score –1.5 SD in a rural area of Handeni Dis-
trict in North-Eastern Tanzania, which has intense year-round P. falciparum transmission.
Children with severe wasting (weight-for-age z-score< –3 SD), haemoglobin
concentration< 70 g/L, Plasmodium infection or signs of chronic illness were excluded.
The study was approved by the Ethical Review Committee of Wageningen University, The
Netherlands (ClinicalTrials.gov: NCT00623857) and the National Health Research Ethics
Review sub-Committee, Dar es Salaam, Tanzania. Written individual informed consent was
obtained from parents or primary caretakers.
South African cohort. This study population was a subset of Tswana speaking pre- and
post-menopausal women (n = 686) enrolled as part of the South African arm of the Prospective
Urban and Rural Epidemiological (PURE) study. The PURE study began in 2005. Haematolo-
gical measures utilized in this study were collected in a follow up study conducted in 2010. The
participants were from the North-West Province in South Africa, aged 35 years or older and
were mainly of Tswana (Bantu) ancestry as determined by self-report. Women were only eligi-
ble for this sub-study if they were apparently healthy, not pregnant, non-lactating and were at
the time of blood collection not diagnosed with any chronic disease or taking drugs for any
chronic disease. Additionally, we included only participants with all outcome measures deter-
mined and who were HIV negative. HIV testing was undertaken with the appropriate pre- and
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post-test counselling as required by South African law. This study was approved by the Ethics
Committee of the North-West University and signed informed consent forms were obtained
from all participants.
African American cohort. This cohort consisted of participants from the Baltimore Lon-
gitudinal Study on Aging (BLSA). The BLSA is a population-based study aimed at evaluating
contributors of healthy aging in the older population residing predominantly in the Baltimore-
Washington DC area [23]. Started in 1958, participants aged 17–94 years were examined every
one to four years depending on their age. Currently, there are approximately 1,100 active par-
ticipants enrolled in the study. For the present study, 228 subjects of African ancestry with
complete data on both genetic and haematological traits were available and were used for the
analysis. The BLSA has continuing approval from the Institutional Review Board (IRB) of
Medstar Research Institute, Johns Hopkins, Bayview Medical Centre, and the University of
Maryland. Additionally, BLSA study participants provide written informed consent to partici-
pate in both direct and ancillary studies related to their collected data.
Iron related measurements
Kenyan and Tanzanian cohorts. For the cross sectional study (Kenyan cohort), serum
ferritin concentrations were determined by enzymatic immunoassay (Ramco Laboratories,
Stafford Texas) and haemoglobin concentration (Hb) was assessed using a hematology ana-
lyzer (Celltac-α, MEK-6410K, Nihon Kohden Corporation, Tokyo, Japan). Serum concentra-
tions of CRP were determined by immunoturbidometric assay on a Cobas Integra 800 system
(Roche Diagnostics, Mannheim, Germany). For the Kenyan randomized trial as well as the
Tanzanian cohort, concentrations of ferritin and concentrations of CRP were measured on a
Beckman Coulter UniCel DxC 880i analyzer as per manufacturer’s instructions.
South African cohort. Serum ferritin was determined using an enzyme immunoassay pro-
cedure (Ramco Laboratories, Inc, Stafford Texas). Hb concentrations were determined spectro-
photometrically from whole blood using the Hemocue1HB201 haemoglobin meter
(Hemocue AB, Angelholm Sweden). Serum concentrations of CRP were measured from serum
via a particle-enhanced immunoturbidometric assay using Sequential Multiple Analyser Com-
puter (SMAC) using the Konelab20iTM auto analyser (Thermo Fisher Scientific Oy, Vantaa,
Finland). Whole blood was used for the determination of HIV status making use of the First
Response (PMCMedical, India) rapid HIV Card Test. If tested positive, the test was repeated
with the Pareeshak (BHAT Bio-tech India) card test.
African American cohort. Serum ferritin was measured using an immunoassay type two-
stage sandwich method using two antiferritin antibodies (Advia Centaur, Bayer). Haemoglobin
was assessed using SYSMEX XE-series (Sysmex Corporation). Serum concentrations of CRP
were measured using the BNII nephelometer from Dade Behring utilizing a particle enhanced
immunonepholometric assay.
SNP selection, genotyping and quality control procedures
SNP selection. To set up the assay for genotyping it was required to develop a list of refer-
ence SNPs (rs) numbers from Genbank to be included in the analysis. This list was set up by
performing a literature search of Pubmed, Sciencedirect, Ebscohost, HUGE navigator and
Google Scholar using the following keywords:
1. Iron, ferritin, transferrin
2. Anaemia
3. Haemochromatosis
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4. Human
5. SNP, Polymorphism, Mutation
6. Genetic
All abstracts were scanned for appropriateness of use, that is, association or linkage of a
SNP to the haematological parameters or key biomarkers of iron status (Hb, SF, serum trans-
ferrin receptor (sTfR) and body iron (BI)). If appropriate, the reference SNP (rs) number of the
polymorphism was recorded and included in the list to be sent to Illumina for verification of
use in the array. Based on this, we selected 32 SNPs for genotyping. Once SNPs were selected,
genotyping was performed for the Kenyan, Tanzanian and South African cohorts. These data
were complemented with the data we obtained from the African American cohort in the BLSA.
Genotyping and quality control procedures. For the Kenyan, Tanzanian and South Afri-
can cohorts, all 32 rs numbers were submitted to Illumina Technical Support for evaluation
using the Assay Design Tool. Each SNP was scored (varying from 0 to 1) by the same, based on
its compatibility for use in a GoldenGate genotyping assay. SNPs with a score above 0.4 were
chosen for genotyping. No SNP fell out based on these criteria. Genotyping for Kenyan (effi-
cacy trial only), South African and Tanzanian cohorts was conducted using the BeadXpress™
platform. Once genotyping was performed, several quality control procedures were applied.
Lack of a detectable signal after analysis was designated as a failed SNP. SNP clustering was
also assessed visually to determine success of genotyping. SNPs with a GenCall Score of>0.5
and samples with a call rate of0.95 were included in the final analysis. Genotyping was per-
formed for only three SNPs in TMPRSS6 (rs2413450, rs4820268, rs228918), for the Kenyan
pilot study samples using Applied Biosystems TaqMan Assays. Data obtained with this method
were merged with the data from the Kenyan efficacy trial. Eventually, we considered only 20
SNPs that had passed all quality control procedures in all four cohorts for association analyses
(S1 Table).
For the African American cohort, genome-wide genotyping was conducted using the Illu-
mina Infinium HumanHap 550K. Genotyping was completed for 284 subjects, and imputation
of ~2.5 million HapMap SNPs was conducted using 501,764 SNPs that passed quality control
(minor allele frequency> 1%, genotyping completeness> 99%, and Hardy Weinberg-
equilibrium> 0.0001). Imputation was conducted with MACH using the HapMap YRI sample
(HapMap data release rel#23a NCBI B36) as a reference. The candidate iron-homeostasis SNPs
that were either directly genotyped or imputed (with an imputation quality of greater than
r2>0.3) were used for the present analysis.
Statistical analyses
Outcome variables (haemoglobin and serum ferritin concentrations) were determined to be
continuous quantitative traits. Anaemia was defined using different cut offs for each cohort as
cut offs are age dependent [24]. Cut offs were as follows: Hb concentration<11.5 g/dL (Kenyan
cohort),<11 g/dL (Tanzanian cohort),<12 g/dL for the South African and African American
cohorts, while iron deficiency was defined as serum ferritin concentration<15μg/L for Ken-
yan, South African and African American samples, and plasma ferritin concentration<12μg/L
for Tanzanian samples. Log10 transformations were applied to the ferritin outcomes to improve
their fit to the normal distribution. Results from associations involving ferritin were then pre-
sented as back-transformed data. Potential disturbances in the distributions of the genotypes
were tested for deviation from the assumptions of Hardy-Weinberg equilibrium (HWE) by
using the Chi-square test. To compare minor allele frequencies (MAFs) across cohorts, a spider
web graph was generated using Microsoft Excel (Version 2010), including European ancestry
Iron-Related Genes and Associations with Haematological Traits
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populations from the 1000 Genomes Project [20]. Linear regression was used to assess associa-
tions between SNPs and outcome measures. For association testing, genotypes were coded as 0,
1, and 2 reflecting the number of copies of the minor allele (additive genetic model), while
imputed genotypes were coded using fractional counts between 0 and 2 according to the esti-
mated number of copies of each minor allele. All associations were adjusted for age and gender.
Additionally, associations involving ferritin concentrations were adjusted for inflammation by
including CRP concentrations as a covariate in the model. Statistical analyses were performed
using version 20 of the Statistical Package for Social Sciences (SPSS Inc Chicago III) or SAS ver-
sion 9.2 (Cary, NC). All reported P-values were two-tailed, and adjustment for multiple testing
was performed using the false discovery rate (FDR) method. The R program for statistical com-
puting version 2.15.2 [25] was used to perform all meta-analyses and chi square tests con-
ducted to test for heterogeneity between studies. We performed the meta analyses in order to
increase the sample size and obtain a summary statistic. Comparisons of effect sizes and direc-
tions were made within and across populations, and meta-analyses were performed to generate
summary effect estimates with and without including the African American cohort. Statistical
significance for all analyses was defined as α< 0.05, while the q values cut-off was set at 0.10.
Results
There were large differences in age between the cohorts, as the studies from Kenya and Tanza-
nia were pre- and school going children, while the studies from South Africa and the United
States were of adults (Table 1). With the exception of the South African cohort which was all
women, the sex distribution was approximately equal. Prevalence of inflammation was below
5% in the Kenyan and African American cohort and 33% and 43% in the Tanzanian and South
African cohort, respectively. Iron deficiency was highest in the Kenyan cohort (37%) and low-
est in the African American cohort (3%). Anaemia was highest in the Tanzanian cohort (32%)
and lowest in the Kenyan cohort at (7%).
In comparing minor allele frequencies across cohorts, the SNPs genotyped for the present
study were generally observed to be more common in European ancestry cohorts as reported
in the 1000 Genomes Project database (Fig 1). For example, for the commonly investigated
rs4820268 SNP in the TMPRSS6 gene, the frequency of the allele associated with lower iron
Table 1. General characteristics of the study participants in the four cohorts.
n Kenya n Tanzania N South Africa N USA (African
American)
Age, y 628 9.0 (2.1) 609 2.7 (1.3) 686 50.0 (10.0) 228 67.4 (11.0)
Gender (%
female)
628 52 609 51 686 100 228 59
Haemoglobin
(g/dL)
626 13.9 (1.6) 607 10.3 (12.8) 481 13.8 (1.6) 228 13.0 (1.4)
Ferritin (μg/L)$ 623 17.8
(17.0,18.6)
603 31.6 (31.6,
39.8)
686 85.1 (77.6,
93.3)
221 103.4 (96.6)
Inﬂammation
(%)
620 3 609 33 290 43 228 5
Anaemia (%) 626 7 609 32 481 8 227 19
Iron deﬁciency
(%)
623 37 606 18 686 11 227 3
$ Values are geometric means (conﬁdence intervals) or otherwise means (SD); Cut-offs for inﬂammation: C-reactive protein>5mg/L; Iron deﬁciency:
Serum ferritin <15μg/l (Kenyan, South African and African American cohorts), and Plasma ferritin <12μg/L (Tanzanian cohort); Anaemia: Haemoglobin
<11.5 g/dL (Kenyan cohort), <11 g/dL (Tanzanian cohort), or <12 g/dL (South African and African American cohorts).
doi:10.1371/journal.pone.0157996.t001
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status was 27%, 22%, 18%, and 30% in the Kenyan, Tanzanian, South African and African
American cohorts, respectively. According to the 1000 Genomes Project database, this is com-
parable to the 31% reported for Africans, but substantially lower than the 41% reported for
Europeans. Similarly, for rs2413450 (TMPRSS6), MAFs were ~12% in the Kenyan, Tanzanian
and South African cohorts and 24% in the African American cohort, which is comparable to
the MAF for Africans (17%), but again lower than that for Europeans (42%) reported in the
1000 Genomes Project database. On the other hand, rs1421312 (TMPRSS6) was more common
in the African cohorts (Kenya, 58%; Tanzania, 66%; South Africa, 68%; 1000 Genomes, 58%)
compared to the Europeans (41%). For the same SNP (rs1421312), the African American
cohort had a MAF of 43%.
In linear regression analyses with haemoglobin concentrations as the dependent outcome
the minor allele (A) of rs10904850 in CUBN was associated with lower Hb concentrations of
0.38 g/dL (P = 0.02). Lower Hb concentrations were also observed for the minor allele (G) of
rs4820268 in TMPRSS6 (0.28 g/dL; P = 0.01) in the Kenyan children (Table 2). Conversely, the
minor allele (A) of rs10421768 in HAMP was positively associated with increased Hb concen-
trations of 0.37 g/dL (P = 0.01) in the Kenyan population.
After meta-analyses of data from all three African cohorts, the minor allele (T) of rs3811658
in TF was associated with a higher Hb concentration of 0.36 g/dL (P = 0.02) while minor alleles
of both rs2413450 (A) and rs4820268 (G) in TMPRSS6 were associated with lower Hb
Fig 1. Minor allele frequency of common genetic variants related to iron metabolism in four African ancestry populations in comparison to the
African and European population in the 1000 Genomes Project database.MAF 1000 A, Minor allele frequency for Africans-1000 Genomes Project;
MAF 1000 E, Minor allele frequency for Europeans- 1000 Genomes Project.
doi:10.1371/journal.pone.0157996.g001
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concentrations of -0.23 g/dL (P = 0.02) and -0.18 g/dL (P = 0.01) respectively. The associations
of rs3811658, rs2413450 and rs4820268 with Hb remained significant and in the same direc-
tion after including the African American cohort in the meta-analysis. There was no heteroge-
neity between studies for these SNPs.
The minor allele (A) of rs1799852 in TF was associated with lower SF concentrations in the
South African cohort (-0.62 μg/L, P = 0.01). On the other hand the minor allele (A) of
rs1867504 also in TF was associated with increased serum ferritin concentrations (1.04 μg/L,
P = 0.06), in the meta analyses of data from the three African populations.
The minor alleles (C) of rs7385804 in TFR2 was associated with decreased serum ferritin
concentrations in the Kenyan population of -0.86 μg/L (P = 0.02). Lowered serum ferritin con-
centrations were also observed for rs1800629 (A) in TNF (-0.76 μg/L, P = 0.03, respectively)
within the African American cohort (Table 3). No significant associations were observed in the
meta analyses including the African American cohort though associations of the minor alleles
of rs1525892 (P = 0.05), rs1867504 (P = 0.06) and rs 3811647 (P = 0.05) in TF and rs10421768
inHAMP (P = 0.06) with ferritin concentrations were nearly significant (S1 Table). Complete
information on associations of all 20 SNPs with concentrations of haemoglobin and ferritin
can be found in the supplementary table (S1 Table).
None of the associations for either Hb or SF as outcome measures were significant after
FDR correction for multiple testing.
Discussion
We report here one of the few candidate gene association studies focussing on the genetics of
iron status in various African ancestry populations. In the meta analyses involving all four
cohorts, we have observed small differences in Hb concentrations between genotype groups:
slightly lower Hb concentrations were associated with the minor alleles A of rs2413450 and G
of rs4820268, both in the TMPRSS6 gene and higher Hb concentrations involving the minor
allele T in rs3811658 in the TF gene. In similar investigations involving ferritin concentrations,
the minor allele A of rs1867504 in TF was associated with higher ferritin concentrations. Addi-
tionally, there were marginally significant associations with higher ferritin concentrations for
the minor alleles of rs1525892, and rs3811647 in TF, rs7385804 in TFR2 and rs10421768 in
HAMP. We further observed that many of the candidate SNPs genotyped in our cohorts, were
more common in the European ancestry cohort in the 1000 Genomes Project as compared to
our African ancestry cohorts.
The most consistent association in terms of direction as well as statistical significance was
observed for rs2413450 and rs4820268 in the TMPRSS6 gene, both associated with lower Hb
concentration. Similar observations have previously been made within populations of Euro-
pean and Asian ancestry [7, 10, 26, 27]. The exact mechanism through which TMPRSS6 action
is exerted is still under investigation. It has generally been hypothesised that TMPRSS6 poly-
morphisms affect hepcidin antimicrobial peptide (HAMP) transcription, thereby influencing
hepcidin concentrations in response to systemic iron concentrations [28–30]. However, two
recent studies [31, 32] did not confirm an intermediate role for hepcidin in the SNP-iron status
parameter associations. Currently, it is proposed that matriptase-2 could regulate hepcidin
expression by cleaving HJV to decrease BMP-SMAD signalling [33].
Several TF variants (rs3811658, rs1867504 and rs1799852) were also significantly associated
with various iron status measures. In contrast to what is known from other studies, we
observed associations between rs3811658 in the TF gene with higher Hb concentrations. This
SNP is in linkage disequilibrium with rs3811647 that has previously been negatively associated
with serum iron, body iron, transferrin saturation and serum ferritin concentrations and
Iron-Related Genes and Associations with Haematological Traits
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positively associated with serum transferrin concentrations [9, 34]. Also, the SNP has been
associated with increased risk of iron deficiency in a population of men and women of Euro-
pean descent [35]. As we would have expected to see negative associations between rs3811658
with haemoglobin concentrations, our finding requires further investigation.
The variant rs1867504 in TF has previously been associated with increased serum transfer-
rin concentrations in a cohort of European ancestry [9] but not with serum ferritin as seen in
our study. It is possible that this variant has pleiotropic effects on ferritin as has previously
been observed for other TF SNPs [9].
Previously, three variants in TF (rs3811647, rs1799852 and rs2280673) plus the HFE C282Y
mutation have been observed to explain approximately 40% of genetic variation in serum
transferrin [9]. We only observed a significant association of rs1799852 with serum ferritin in
the South African cohort. Furthermore, we did not have information on rs2280673 and HFE
C282Y. We therefore could not replicate this previously observed association.
TF is a crucial biological carrier of iron in blood plasma[36]. Severe mutations in the trans-
ferrin gene lead to atransferrinaemia [37] and have been determined to cause microcytic anae-
mia accompanied by hepatic accumulation of iron in humans [38] and mice [39]. Further
investigations into the influence of various TF variants on haematological traits are therefore
required.
A large portion of systemic iron deficiency undoubtedly results from non-genetic factors.
Environmental factors such as diets low in bioavailable iron [40] as well as a high inflammation
burden [41], are probably the foremost factors predisposing to iron deficiency. High inflamma-
tion burden causes iron to be retained in the reticuloendothelial system, resulting in iron being
unavailable for erythropoiesis [41]. Diets in African populations are typically low in bioavail-
able iron [42]. We corrected for dietary iron intake in the African American as well as South
African cohorts (not presented), but the difference between the crude and adjusted regression
models was negligible. To account for other environmental and individual influences on iron
status, we adjusted our regression models for major biological confounders that are known to
affect Hb and ferritin concentrations including age, gender [43] and the inflammatory acute
phase protein CRP [41] to increase precision of our estimates. Age and gender are known to
influence iron status [44, 45]. Although we corrected the associations with serum ferritin as the
outcome for CRP, we may not have captured the inflammation at later convalescence.
It is noteworthy that we did observe population specific significant associations that were
not replicated in all cohorts. This was particularly observed in the Kenyan cohort that consisted
of school going children (mean age 9.0 years). In this cohort we specifically highlight the asso-
ciation of the A allele of rs10421768 in HAMP with Hb and the C allele of rs7385804 in TFR2.
The HAMP gene encodes hepcidin, which is a 25-amino acid peptide produced and secreted
mainly by hepatocytes and is a major regulator of systemic iron homeostasis [33]. As far as we
know, no functional studies have investigated the effect of rs10421768 on dysregulation of hep-
cidin expression in humans. Based on our data, we speculate that this SNP down regulates
HAMP, thereby increasing the amount of iron in circulation available for erythropoiesis.
Indeed, we observed rs10421768 in HAMP to be consistently associated with higher serum fer-
ritin concentrations across all study populations (S1 Table).
The SNP rs7385804 has previously been associated with reduced serum iron, serum trans-
ferrin and transferrin saturation concentrations in a cohort of elderly Chinese women [26].
TFR2 polymorphisms have also been reported to be associated with red blood cell count and
mean cell volume [46–48]. In terms of function, TFR2 is believed to be involved in the hepcidin
regulation pathway [49]. The fact that SNPs directly linked to hepcidin were observed to be
associated with various iron status measures underscores the key role that hepcidin could play
in determining iron status in the Kenyan cohort. The children in this cohort did not reside in a
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malaria endemic area and based on CRP concentrations did not have a high prevalence of
inflammation, both of which are likely to impact significantly on hepcidin concentrations.
Hepcidin however responds to signals from diverse physiological processes: it can be induced
by infection, inflammation and iron loading and suppressed by iron deficiency, hypoxia, and
expanded erythropoiesis [50]. We hypothesise this observation is because the typical diet of
this cohort of children is low in iron which would impact on iron loading thereby having an
impact on hepcidin response.
Within the African American population, rs1800629 in TNF was significantly associated
with lower plasma ferritin concentrations. This SNP has previously been associated with iron
deficiency as part of a haplotype together with other TNF SNPs [51], as well as with an
increased risk of severe anemia in low-birth-weight children in Kenya [52] and increased risk
of severe malarial anemia in Gambian children [53]. It has been suggested previously that this
haplotype would only influence iron status due to pressure of infectious diseases [51] However,
our African American cohort consisted of apparently healthy elderly subjects who are not at
risk of developing malaria. Nevertheless, there may still have been undetected low grade
inflammation from undiagnosed infections or diseases in this elderly population. Disease
induced inflammatory processes may therefore underlie this observation.
A limitation inherent to our study is that age and sex distributions differed radically between
some of the cohorts analyzed and therefore simple adjustments may not have eliminated all
confounding by these variables. In future studies, including cohorts that are more similar in
aspects such as age and sex would be desirable. Additionally, our cohorts were smaller than
those used in GWA studies and therefore may have lacked power to confirm previously
observed associations. Indeed none of the associations with either Hb or SF as outcome mea-
sures were significant after FDR correction for multiple testing. The sample size for detecting
associations between disease and SNP markers is affected by prevalence of the condition under
study, allele frequency, linkage disequilibrium (LD), inheritance models (e.g., additive, domi-
nant, and multiplicative models), and effect size of the genetic variants (e.g., odds ratio, relative
risk, etc.) [54–56]. We conducted a retrospective sample size calculation in which we assumed
an additive model. From the calculation, 780 individuals are required to conduct association
analyses for a SNP explaining 1% of the variation in the outcome measure, with α = 0.05 and
power of 80%. If the genetic variant is one of 20 independent genetic variants tested, adjust-
ment for multiple testing using a Bonferroni correction would require a significance level of
0.05/20 or 0.0025 as the threshold. To detect this same association at this adjusted significance
level, with 80% power would require a large increase in sample size.
We observed large differences in MAF of investigated SNPs between our study cohorts and
those of the Europeans included in the 1000 Genomes project. This may be due to selective
pressure caused by environmental conditions thereby altering the frequency of genetic variants
between different populations [57]. Theoretically, these differences in MAF between popula-
tions could result in dissimilarities in the prevalence of a disease outcome, for example iron
deficiency, and in the case of strong gene-disease associations call for population specific strate-
gies to address this.
All of our cohorts were not specifically designed to study the genetics of iron metabolism
and therefore not all of the factors taken into account in sample size calculation were consid-
ered. However our study does offer an initial indication of what genetic loci would be impor-
tant for haematological traits in African ancestry cohorts. Another important consideration
not taken into account in our analyses is the linkage disequilibrium structure in African ances-
try populations, which is different from that of Europeans resulting from the greater variation
within the genome of African ancestry populations [58]. It is thus possible that actual disease
markers tagged by the investigated SNPs in European populations are not in LD in our African
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cohorts, and could explain why only a few significant associations were observed. A recent
genome wide admixture and association study indeed discovered novel loci to be associated
with iron status in an African-American population [59].
In conclusion, we have attempted to replicate reported associations between genetic loci
and iron status indicators from European ancestry populations in various African ancestry
populations with limited success. This may partly be due to the greater genetic variation within
the African ancestry populations [60] which limits the transferability of findings from Euro-
pean ancestry populations. Additionally, populations vary by ethnicity in terms of allele fre-
quencies and biological adaptations due to various environmental factors. For these reasons,
population specific genomic studies are warranted. GWA studies in African ancestry popula-
tions can potentially reveal novel genetic variants that are specific to these populations. In addi-
tion, functional studies are required to further explore the mechanisms involved in the
regulation of iron metabolism.
Supporting Information
S1 Table. Associations of single nucleotide polymorphism with iron status parameters.
SNP = Single nucleotide polymorphism; Ke = Kenyan cohort; Tz = Tanzanian cohort;
SA = South African cohort; AA = African American cohort; P(Het) = P value of heterogeneity
testing; Met- = meta analyses of beta and SE values from African cohorts; Met_All = meta anal-
yses of beta and SE values from all cohorts (Afrian+African American); Direction = direction
of association based on beta value Hb = Haemoglobin, Values in bold are significant. Results
are presented as mean (SE) change per copy of the minor allele from regression analysis using
additive genetic model and with adjustment for age and sex for associations involving Hb; and
for age, sex and CRP concentrations for associations involving ferritin. † Values not adjusted
for gender as all participants were women. Values in bold are significant before FDR correction
for multiple testing. Explained variance ranged from< 1% to 3%, with the largest explained
variety being 3% for rs10421768 in the Kenyan population.
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